133 related articles for article (PubMed ID: 11438523)
21. A non-thiazolidinedione partial peroxisome proliferator-activated receptor gamma ligand inhibits vascular smooth muscle cell growth.
Bruemmer D; Berger JP; Liu J; Kintscher U; Wakino S; Fleck E; Moller DE; Law RE
Eur J Pharmacol; 2003 Apr; 466(3):225-34. PubMed ID: 12694805
[TBL] [Abstract][Full Text] [Related]
22. Peroxisome proliferator-activated receptor (PPAR) gamma coactivator-1 recruitment regulates PPAR subtype specificity.
Oberkofler H; Esterbauer H; Linnemayr V; Strosberg AD; Krempler F; Patsch W
J Biol Chem; 2002 May; 277(19):16750-7. PubMed ID: 11875072
[TBL] [Abstract][Full Text] [Related]
23. Peroxisome proliferator-activated receptor-gamma ligand inhibition of RANTES production by human endometriotic stromal cells is mediated through an upstream promoter element.
Pritts EA; Zhao D; Sohn SH; Chao VA; Waite LL; Taylor RN
Fertil Steril; 2003 Aug; 80(2):415-20. PubMed ID: 12909507
[TBL] [Abstract][Full Text] [Related]
24. Peroxisome proliferator-activated receptor-gamma ligands inhibit nuclear but not cytosolic extracellular signal-regulated kinase/mitogen-activated protein kinase-regulated steps in vascular smooth muscle cell migration.
Goetze S; Kintscher U; Kim S; Meehan WP; Kaneshiro K; Collins AR; Fleck E; Hsueh WA; Law RE
J Cardiovasc Pharmacol; 2001 Dec; 38(6):909-21. PubMed ID: 11707695
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of IkappaB kinase and IkappaB phosphorylation by 15-deoxy-Delta(12,14)-prostaglandin J(2) in activated murine macrophages.
Castrillo A; Díaz-Guerra MJ; Hortelano S; Martín-Sanz P; Boscá L
Mol Cell Biol; 2000 Mar; 20(5):1692-8. PubMed ID: 10669746
[TBL] [Abstract][Full Text] [Related]
26. Peroxisome proliferator activator receptor-gamma ligands, 15-deoxy-Delta(12,14)-prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways.
Zingarelli B; Sheehan M; Hake PW; O'Connor M; Denenberg A; Cook JA
J Immunol; 2003 Dec; 171(12):6827-37. PubMed ID: 14662889
[TBL] [Abstract][Full Text] [Related]
27. [An experimental study on the reverse mechanism of PPAR-gamma agonist rosiglitazone in rats with non-alcoholic steatohepatitis].
Zhao CY; Wang YD; Zhou JY; Jia B; Cui JF
Zhonghua Gan Zang Bing Za Zhi; 2007 Jun; 15(6):450-5. PubMed ID: 17594812
[TBL] [Abstract][Full Text] [Related]
28. Peroxisome proliferator-activated receptor-gamma agonists modulate macrophage activation by gram-negative and gram-positive bacterial stimuli.
Guyton K; Zingarelli B; Ashton S; Teti G; Tempel G; Reilly C; Gilkeson G; Halushka P; Cook J
Shock; 2003 Jul; 20(1):56-62. PubMed ID: 12813370
[TBL] [Abstract][Full Text] [Related]
29. Regulation of murine macrophage proinflammatory and anti-inflammatory cytokines by ligands for peroxisome proliferator-activated receptor-gamma: counter-regulatory activity by IFN-gamma.
Alleva DG; Johnson EB; Lio FM; Boehme SA; Conlon PJ; Crowe PD
J Leukoc Biol; 2002 Apr; 71(4):677-85. PubMed ID: 11927655
[TBL] [Abstract][Full Text] [Related]
30. Induction of heme oxygenase-1 expression in murine macrophages is essential for the anti-inflammatory effect of low dose 15-deoxy-Delta 12,14-prostaglandin J2.
Lee TS; Tsai HL; Chau LY
J Biol Chem; 2003 May; 278(21):19325-30. PubMed ID: 12642589
[TBL] [Abstract][Full Text] [Related]
31. The gene encoding the Acyl-CoA-binding protein is activated by peroxisome proliferator-activated receptor gamma through an intronic response element functionally conserved between humans and rodents.
Helledie T; Grøntved L; Jensen SS; Kiilerich P; Rietveld L; Albrektsen T; Boysen MS; Nøhr J; Larsen LK; Fleckner J; Stunnenberg HG; Kristiansen K; Mandrup S
J Biol Chem; 2002 Jul; 277(30):26821-30. PubMed ID: 12015306
[TBL] [Abstract][Full Text] [Related]
32. PPAR-gamma ligands modulate effects of LPS in stimulated rat synovial fibroblasts.
Simonin MA; Bordji K; Boyault S; Bianchi A; Gouze E; Bécuwe P; Dauça M; Netter P; Terlain B
Am J Physiol Cell Physiol; 2002 Jan; 282(1):C125-33. PubMed ID: 11742805
[TBL] [Abstract][Full Text] [Related]
33. Nanomolar and micromolar effects of 15-deoxy-delta 12,14-prostaglandin J2 on amnion-derived WISH epithelial cells: differential roles of peroxisome proliferator-activated receptors gamma and delta and nuclear factor kappa B.
Berry EB; Keelan JA; Helliwell RJ; Gilmour RS; Mitchell MD
Mol Pharmacol; 2005 Jul; 68(1):169-78. PubMed ID: 15821150
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis.
Tsubouchi Y; Sano H; Kawahito Y; Mukai S; Yamada R; Kohno M; Inoue K; Hla T; Kondo M
Biochem Biophys Res Commun; 2000 Apr; 270(2):400-5. PubMed ID: 10753637
[TBL] [Abstract][Full Text] [Related]
35. Contribution of cyclopentenone prostaglandins to the resolution of inflammation through the potentiation of apoptosis in activated macrophages.
Hortelano S; Castrillo A; Alvarez AM; Boscá L
J Immunol; 2000 Dec; 165(11):6525-31. PubMed ID: 11086094
[TBL] [Abstract][Full Text] [Related]
36. Agonists of peroxisome proliferator-activated receptor gamma inhibit cell growth in malignant melanoma.
Mössner R; Schulz U; Krüger U; Middel P; Schinner S; Füzesi L; Neumann C; Reich K
J Invest Dermatol; 2002 Sep; 119(3):576-82. PubMed ID: 12230498
[TBL] [Abstract][Full Text] [Related]
37. Tumor necrosis factor alpha-induced pancreatic beta-cell insulin resistance is mediated by nitric oxide and prevented by 15-deoxy-Delta12,14-prostaglandin J2 and aminoguanidine. A role for peroxisome proliferator-activated receptor gamma activation and inos expression.
Kwon G; Xu G; Marshall CA; McDaniel ML
J Biol Chem; 1999 Jun; 274(26):18702-8. PubMed ID: 10373483
[TBL] [Abstract][Full Text] [Related]
38. Ligands of peroxisome proliferator-activated receptor-gamma block activation of pancreatic stellate cells.
Masamune A; Kikuta K; Satoh M; Sakai Y; Satoh A; Shimosegawa T
J Biol Chem; 2002 Jan; 277(1):141-7. PubMed ID: 11606585
[TBL] [Abstract][Full Text] [Related]
39. The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor gamma and IkappaB kinase activities.
Makowski L; Brittingham KC; Reynolds JM; Suttles J; Hotamisligil GS
J Biol Chem; 2005 Apr; 280(13):12888-95. PubMed ID: 15684432
[TBL] [Abstract][Full Text] [Related]
40. 15-Deoxy-delta12,14-PGJ2, but not troglitazone, modulates IL-1beta effects in human chondrocytes by inhibiting NF-kappaB and AP-1 activation pathways.
Boyault S; Simonin MA; Bianchi A; Compe E; Liagre B; Mainard D; Bécuwe P; Dauça M; Netter P; Terlain B; Bordji K
FEBS Lett; 2001 Jul; 501(1):24-30. PubMed ID: 11457450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
